210238-07-6

Basic information

• Product Name: (2R,3R,4S,5R)-2-{6-(2,2-Diphenyl-ethylamino)-2-[2-(1-methyl-1H-imidazol-4-yl)-ethylamino]-purin-9-yl}-5-(2-methyl-2H-tetrazol-5-yl)-tetrahydro-furan-3,4-diol Formate
• CAS NO: 210238-07-6
• Molecular Weight: 668.715
• Mol File: 210238-07-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2R,3R,4S,5R)-2-{6-(2,2-Diphenyl-ethylamino)-2-[2-(1-methyl-1H-imidazol-4-yl)-ethylamino]-purin-9-yl}-5-(2-methyl-2H-tetrazol-5-yl)-tetrahydro-furan-3,4-diol Formate(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3R,4S,5R)-2-{6-(2,2-Diphenyl-ethylamino)-2-[2-(1-methyl-1H-imidazol-4-yl)-ethylamino]-purin-9-yl}-5-(2-methyl-2H-tetrazol-5-yl)-tetrahydro-furan-3,4-diol Formate(210238-07-6)
• EPA Substance Registry System: (2R,3R,4S,5R)-2-{6-(2,2-Diphenyl-ethylamino)-2-[2-(1-methyl-1H-imidazol-4-yl)-ethylamino]-purin-9-yl}-5-(2-methyl-2H-tetrazol-5-yl)-tetrahydro-furan-3,4-diol Formate(210238-07-6)

Safety Data

• Hazardous Substances Data: 210238-07-6(Hazardous Substances Data)

Upstream product

• 501-75-7 N₁-methylhistamine 
• 3963-62-0 2,2-Diphenylethylamine 

Relevant articles and documents

2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives

There are provided according to the invention novel compounds of formula I wherein R1, R2 and R3 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.